Community-acquired pneumonia in Korean children: time to read between the lines

Article information

Clin Exp Pediatr. 2023;66(1):22-23
Publication date (electronic) : 2022 November 10
doi :
Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
Corresponding author: Dong In Suh, MD, PhD. Department of Pediatrics, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea Email:
Received 2022 July 17; Revised 2022 August 16; Accepted 2022 September 14.

Key message

∙ Various studies have reported the etiology of community-acquired pneumonia (CAP) in Korean children

∙ Factors other than etiology are equally important to a comprehensive understanding of CAP

∙ Knowledge from archived reports is no longer directly applicable to the current CAP and requires careful modification

Pneumonia is among the leading causes of death among younger children worldwide [1] and the major cause of death among the general population of Korea [2]. Recent Korean statistics indicate that pneumonia and respiratory diseases are no longer leading causes of death among children [2]. This may be due to improvements in hygiene, successful vaccination programs, and pediatrician effort and dedication.

Selecting appropriate chemotherapeutic agents for the pathogen and providing good conservative care are fundamental to pneumonia management. Nevertheless, for patients with community-acquired pneumonia (CAP), especially those who are not hospitalized, empirical treatment without identifying the causative microorganism is favored. As most affected patients are immunocompetent, this method is generally effective. Indeed, since 2015, the Korea Centers for Disease Control and Prevention has provided surveillance data on respiratory infection pathogens to aid the timely control of infections [3].

Although choosing treatments based on previously archived information is simple and intuitive, several factors must be considered before applying this knowledge to a particular circumstance (Fig. 1). This is comparable to the so-called distributional shift, an algorithm trained with artificial intelligence that, while accurate and efficient in the same setting in which it was trained, produces startlingly inaccurate results when directly applied to clinical practice outside the training environment [4]. In this context, although epidemiological information about pathogens is important, it is important to understand how the information was collected.

Fig. 1.

Factors that influence each community-acquired pneumonia profile.

The review introduced in this issue organized by Roh et al. [5] provides essential information for determining the appropriate treatment strategies for CAP. The authors published an original study of respiratory samples and clinical data regarding the characteristics of patients with CAP and causative pathogens among Korean children [6]. Since it included as many as 1,023 children who met the CAP criteria from 27 secondary and tertiary medical institutions spread across 6 metropolitan areas, it should be considered to provide more relevant Korean data than any other previous report. On the other hand, it also provides a comprehensive summary of all available reports on pneumonia in Korean children [5]. In particular, the summary presented in Table 2 has great value because it describes common pathogen profiles and additional data such as age, region, collection period, and target group. Physicians exploring the optimal empirical treatment for their patients are likely to refer to these data as a guide.

Furthermore, this review is outstanding because the authors investigated situational factors that require consideration when interpreting epidemiological data. A good example is the serotypes and names of prevalent bacteria as well as their alterations according to the implementation of the Korean national immunization program. The article also clarifies several limitations that readers may encounter when analyzing archived data. For instance, no one can guarantee that an identified pathogen is a causal agent of CAP and not a mere bystander. Similarly, bacterial pneumonia cannot be excluded simply because no microorganisms grow in the culture medium. Recent studies utilizing gene sequencing to identify bacterial pathogens confirmed the latter hypothesis [7].

Finally, other factors should be considered. Etiologies that are currently epidemics are particularly important. For a specific virus, such as the pandemic influenza A (H1N1) virus in 2010 [8] or SARS-CoV-2 in 2022 [9], CAP cases caused by other viruses will inevitably decrease proportionally. Furthermore, mycoplasma epidemics occur every 3 to 4 years [10] that complicate statistics when we CAP a seasonal disease.

In conclusion, the epidemiological data of CAP have become complex to interpret. Significant changes have occurred over the past 2 years that require the division of cases into 2 categories: pre-coronavirus disease (pre-COVID-19) and post-COVID-19. Accordingly, we must reexamine how we would interpret pre-pandemic data and seek reasonable ways to apply this knowledge to postpandemic CAP cases. Additional research is required to reflect the postpandemic effects of social isolation, personal hygiene, and health improvement on the management of children with CAP.


Conflicts of interest

No potential conflict of interest relevant to this article was reported.


1. Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc Health 2022;6:106–15.
2. Korean Statistical Information Service. Causes of death statistics [Internet]. Daejeon (Korea): Statistics Korea; 2022. [cited 2022 Jul 15]. Available from:;F_27.2;#F_27.2.
3. Korea Disease Control and Prevention Agency. Sentinel acute respiratory infection surveillance in Korea [Internet]. Cheongju (Korea): Korea Disease Control and Prevention Agency; 2022. [cited 2022 Jul 15] Available from:
4. Challen R, Denny J, Pitt M, Gompels L, Edwards T, Tsaneva-Atanasova K. Artificial intelligence, bias and clinical safety. BMJ Qual Saf 2019;28:231–7.
5. Roh EJ, Shim JY, Chung EH. Epidemiology and surveillance implications of community-acquired pneumonia in children. Clin Exp Pediatr 2022;65:563–73.
6. Roh EJ, Lee MH, Lee JY, Kim HB, Ahn YM, Kim JK, et al. Analysis of national surveillance of respiratory pathogens for community-acquired pneumonia in children and adolescents. BMC Infect Dis 2022;22:330.
7. Goelz H, Wetzel S, Mehrbarzin N, Utzolino S, Häcker G, Badr MT. Next- and third-generation sequencing outperforms culture-based methods in the diagnosis of ascitic fluid bacterial infections of ICU patients. Cells 2021;10:3226.
8. Ko JH, Kim JH, Kang JH, Kim JH, Eun BW, Kim KH, et al. Characteristics of hospitalized children with 2009 pandemic influenza A (H1N1): a multicenter study in Korea. J Korean Med Sci 2012;27:408–15.
9. Lee H, Choi S, Park JY, Jo DS, Choi UY, Lee H, et al. Analysis of critical COVID-19 cases among children in Korea. J Korean Med Sci 2022;37e13.
10. Lee E, Kim CH, Lee YJ, Kim HB, Kim BS, Kim HY, et al. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea. BMC Infect Dis 2020;20:132.

Article information Continued

Fig. 1.

Factors that influence each community-acquired pneumonia profile.